100+ Vendors
50+ Compounds
100+ Vendor COAs
Price/MG Comparison
Exclusive Coupons

Phase III / NDA Filed

Thymosin Alpha-1

Immune ResearchThymus PeptideThymalfasin

From

$42.99

Vendors

20

Lab tested

3 COAs

Key benefits

  • Approved outside the US for hepatitis B
  • Supports T-cell immune activity
  • Studied as an add-on to vaccines and cancer care
Thymosin Alpha-1 (thymalfasin) is a 28-amino-acid peptide first isolated from the thymus. It supports T-cell function and has been studied as an immune modulator in chronic hepatitis B and C, in vaccine response and alongside cancer treatment.

Regulatory activity

Phase III / NDA Filed

Late-stage human trials

Route

Subcutaneous

Often studied away from meals; timing varies by protocol.

Cycle

Varies by study

Typical duration

Storage

-20°C lyophilized · 2–8°C once reconstituted

Follow vendor guidance

Marketplace

Compare all Thymosin Alpha-1 vendors

Prices per size, coupon codes, lab reports and shipping.

21 offers

What the research reports

Research Benefits of Thymosin Alpha-1

What published research has reported so far. These are research findings, not promised results.

01

Approved outside the US for hepatitis B

02

Supports T-cell immune activity

03

Studied as an add-on to vaccines and cancer care

What the evidence shows

Thymosin Alpha-1 has been through many human clinical trials and is approved in a number of countries, under the brand name Zadaxin, mainly for chronic hepatitis B. It is not approved by the FDA in the US, and results in other conditions have been mixed.

Safety and regulatory position

Approved outside the US · not FDA approved

As thymalfasin, it is approved as a prescription medicine in several countries and has a long record of use in clinical settings. It is not FDA approved, and research-grade vials sold by vendors are not the same as the regulated medicine.

FAQ

Frequently asked questions.

Thymalfasin is the drug name for synthetic Thymosin Alpha-1. It is sold as Zadaxin in countries where it is approved.